Mediclinic International PLC
Mr. Alan Grieve serves as Independent Non-Executive Director of Mediclinic International Plc. He was appointed as an Independent Non-executive Director of the Company on 15 February 2016 upon the successful combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited. Prior to the combination, he served as an independent non-executive director of Mediclinic International Limited since 2012. Mr Grieve is a nonexecutive director of Reinet Investments Manager S.A., having served as Chief Executive Offi cer of the company from 2012 to 2014 and Chief Financial Offi cer from 2008 to 2011. He is a former Director of Corporate Aff airs of Compagnie Financière Richemont S.A. Prior to joining the Richemont group in 1986, he worked with Price Waterhouse & Co (now PricewaterhouseCoopers) and Arthur Young (now Ernst & Young). He holds an Honours degree in Business Administration from Heriot-Watt University (B.A. (Hons)); and is also a qualified Chartered Accountant with the Institute of Chartered Accountants.
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology